82 related articles for article (PubMed ID: 23281932)
1. Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistance.
Troiani T; Zappavigna S; Martinelli E; Addeo SR; Stiuso P; Ciardiello F; Caraglia M
Expert Opin Biol Ther; 2013 Feb; 13(2):241-55. PubMed ID: 23281932
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor antagonists in colorectal cancer: emerging strategies for precision therapy.
González NS; Marchese PV; Baraibar I; Ros J; Salvà F; Rodríguez M; Salvà C; Vaghi C; Alcaraz A; García A; Tabernero J; Élez E
Expert Opin Investig Drugs; 2024 May; ():1-13. PubMed ID: 38775361
[TBL] [Abstract][Full Text] [Related]
3. Molecular docking analysis of cetuximab with NOTCH signalling pathway targets for oral cancer.
Pazhani J; Veeraraghavan VP; Jayaraman S
Bioinformation; 2023; 19(4):471-473. PubMed ID: 37822809
[TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor, ionotropic, N‑methyl D‑aspartate‑associated protein 1 promotes colorectal cancer cell proliferation and metastasis, and is negatively regulated by miR‑296‑3p.
Yan Z; Li P; Xue Y; Tian H; Zhou T; Zhang G
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34368871
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing.
Liang YH; Tsai JH; Cheng YM; Chan KY; Hsu WL; Lee CC; Chen KH; Yeh KH
Sci Rep; 2021 Apr; 11(1):9080. PubMed ID: 33907276
[TBL] [Abstract][Full Text] [Related]
6. Differential regulation of AMP-activated protein kinase in healthy and cancer cells explains why V-ATPase inhibition selectively kills cancer cells.
Bartel K; Müller R; von Schwarzenberg K
J Biol Chem; 2019 Nov; 294(46):17239-17248. PubMed ID: 31604821
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer.
Conradi LC; Spitzner M; Metzger AL; Kisly M; Middel P; Bohnenberger H; Gaedcke J; Ghadimi MB; Liersch T; Rüschoff J; Beißbarth T; König A; Grade M
BMC Cancer; 2019 Sep; 19(1):880. PubMed ID: 31488078
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of NRAS Gene for Survival of Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Hu Y; Tao SY; Deng JM; Hou ZK; Liang JQ; Huang QG; Li LH; Li HB; Chen YM; Yi H; Chen XL; Liu H
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3001-3008. PubMed ID: 30484984
[TBL] [Abstract][Full Text] [Related]
9. Chemotaxis Model for Breast Cancer Cells Based on Signal/Noise Ratio.
Lim S; Nam H; Jeon JS
Biophys J; 2018 Nov; 115(10):2034-2043. PubMed ID: 30366624
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab intensifies the ADCC activity of adoptive NK cells in a nude mouse colorectal cancer xenograft model.
Chen S; Li X; Chen R; Yin M; Zheng Q
Oncol Lett; 2016 Sep; 12(3):1868-1876. PubMed ID: 27602116
[TBL] [Abstract][Full Text] [Related]
11. [EGFR inhibition in NSCLC tumor cell lines : Influence on cell cycle and tumor control].
Gaipl US
Strahlenther Onkol; 2016 Jun; 192(6):425-7. PubMed ID: 27169393
[No Abstract] [Full Text] [Related]
12. Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer.
Chen Y; Shi Y; Lin J; Ye YB; Wang XJ; Chen G; Guo ZQ
Medicine (Baltimore); 2015 Oct; 94(40):e1698. PubMed ID: 26448020
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-106b promotes colorectal cancer cell migration and invasion by directly targeting DLC1.
Zhang GJ; Li JS; Zhou H; Xiao HX; Li Y; Zhou T
J Exp Clin Cancer Res; 2015 Jul; 34(1):73. PubMed ID: 26223867
[TBL] [Abstract][Full Text] [Related]
14. Standard chemotherapy with cetuximab for treatment of colorectal cancer.
Li XX; Liang L; Huang LY; Cai SJ
World J Gastroenterol; 2015 Jun; 21(22):7022-35. PubMed ID: 26078581
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF.
Wang Z; Ma B; Ji X; Deng Y; Zhang T; Zhang X; Gao H; Sun H; Wu H; Chen X; Zhao R
Cancer Cell Int; 2015; 15():40. PubMed ID: 25977643
[TBL] [Abstract][Full Text] [Related]
16. AXL is an oncotarget in human colorectal cancer.
Martinelli E; Martini G; Cardone C; Troiani T; Liguori G; Vitagliano D; Napolitano S; Morgillo F; Rinaldi B; Melillo RM; Liotti F; Nappi A; Bianco R; Berrino L; Ciuffreda LP; Ciardiello D; Iaffaioli V; Botti G; Ferraiolo F; Ciardiello F
Oncotarget; 2015 Sep; 6(27):23281-96. PubMed ID: 25966280
[TBL] [Abstract][Full Text] [Related]
17. Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.
López-Knowles E; Wilkerson PM; Ribas R; Anderson H; Mackay A; Ghazoui Z; Rani A; Osin P; Nerurkar A; Renshaw L; Larionov A; Miller WR; Dixon JM; Reis-Filho JS; Dunbier AK; Martin LA; Dowsett M
Breast Cancer Res; 2015 Mar; 17(1):35. PubMed ID: 25888249
[TBL] [Abstract][Full Text] [Related]
18. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
[TBL] [Abstract][Full Text] [Related]
19. The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells.
Kawakami H; Okamoto I; Yonesaka K; Okamoto K; Shibata K; Shinkai Y; Sakamoto H; Kitano M; Tamura T; Nishio K; Nakagawa K
Oncotarget; 2014 Dec; 5(23):11847-56. PubMed ID: 25474137
[TBL] [Abstract][Full Text] [Related]
20. X-linked inhibitor of apoptosis-associated factor l (XAFl) enhances the sensitivity of colorectal cancer cells to cisplatin.
Ju WC; Huang GB; Luo XY; Ren WH; Zheng DQ; Chen PJ; Lou YF; Li B
Med Oncol; 2014 Dec; 31(12):273. PubMed ID: 25367849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
